Evidence map›Paper›PMID 31076402›Full record

ArticleGut2020

Functional microRNA screen uncovers O-linked N-acetylglucosamine transferase as a host factor modulating hepatitis C virus morphogenesis and infectivity.

Katharina Herzog, Simonetta Bandiera, Sophie Pernot, Catherine Fauvelle, Frank Jühling, Amélie Weiss, Anne Bull, Sarah C Durand, Béatrice Chane-Woon-Ming, Sébastien Pfeffer and 7 more

Open access · greenAbstract read
In one paragraph

Article in Gut, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 35 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Decreased miR-329-3p upregulatesInternational journal of medical sciences · 2023
    Article
  9. Review
  10. Review
  11. Review
  12. ProteinFrontiers in immunology · 2022
    Review
  13. Review
  14. Review
  15. Role ofPhysiological reviews · 2021
    Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Frontiers in immunology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 4 institutions in 1 country.

Katharina Herzog *Inserm, U1110, Institut de Recherche sur les Maladies Virales et Hépatiques, Strasbourg, France.
Simonetta Bandiera *Inserm, U1110, Institut de Recherche sur les Maladies Virales et Hépatiques, Strasbourg, France.
Sophie PernotInserm, U1110, Institut de Recherche sur les Maladies Virales et Hépatiques, Strasbourg, France.
Catherine FauvelleInserm, U1110, Institut de Recherche sur les Maladies Virales et Hépatiques, Strasbourg, France.
Frank JühlingInserm, U1110, Institut de Recherche sur les Maladies Virales et Hépatiques, Strasbourg, France.
Amélie WeissUniversity of Strasbourg, Strasbourg, France.
Anne BullInserm, U1259, Faculté de Médecine, Université François Rabelais and CHRU de Tours, Tours, France.
Sarah C DurandInserm, U1110, Institut de Recherche sur les Maladies Virales et Hépatiques, Strasbourg, France.
Béatrice Chane-Woon-MingUniversity of Strasbourg, Strasbourg, France.
Sébastien PfefferUniversity of Strasbourg, Strasbourg, France.
Marion MerceyInstitute for Applied Biosciences, Centre de Recherche UGA, Inserm U1209 - CNRS 5309, Grenoble, France.
Hervé LeratInstitute for Applied Biosciences, Centre de Recherche UGA, Inserm U1209 - CNRS 5309, Grenoble, France.
Jean-Christophe MeunierInserm, U1259, Faculté de Médecine, Université François Rabelais and CHRU de Tours, Tours, France.
Wolfgang RaffelsbergerUniversity of Strasbourg, Strasbourg, France.
Laurent BrinoUniversity of Strasbourg, Strasbourg, France.
Thomas F BaumertInserm, U1110, Institut de Recherche sur les Maladies Virales et Hépatiques, Strasbourg, France.ORCID 0000-0002-9022-5611
Mirjam B ZeiselInserm, U1110, Institut de Recherche sur les Maladies Virales et Hépatiques, Strasbourg, France.ORCID 0000-0003-1606-0131
Centre National de la Recherche Scientifique · FRInserm · FRUniversité de Tours · FRUniversité Claude Bernard Lyon 1 · FR

Funding

Shared Resource CoresP01HL107153 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI HART, GERALD WARREN · 2011 to 2017
$16.8M
NHLBI NIH HHS P01 HL107153
6 · The paper itself

Abstract

objectiveInfection of human hepatocytes by the hepatitis C virus (HCV) is a multistep process involving both viral and host factors. microRNAs (miRNAs) are small non-coding RNAs that post-transcriptionally regulate gene expression. Given that miRNAs were indicated to regulate between 30% and 75% of all human genes, we aimed to investigate the functional and regulatory role of miRNAs for the HCV life cycle.

designTo systematically reveal human miRNAs affecting the HCV life cycle, we performed a two-step functional high-throughput miRNA mimic screen in Huh7.5.1 cells infected with recombinant cell culture-derived HCV. miRNA targeting was then assessed using a combination of computational and functional approaches.

resultsWe uncovered miR-501-3p and miR-619-3p as novel modulators of HCV assembly/release. We discovered that these miRNAs regulate O-linked N-acetylglucosamine (O-GlcNAc) transferase (OGT) protein expression and identified OGT and O-GlcNAcylation as regulators of HCV morphogenesis and infectivity. Furthermore, increased OGT expression in patient-derived liver tissue was associated with HCV-induced liver disease and cancer.

conclusionmiR-501-3p and miR-619-3p and their target OGT are previously undiscovered regulatory host factors for HCV assembly and infectivity. In addition to its effect on HCV morphogenesis, OGT may play a role in HCV-induced liver disease and hepatocarcinogenesis.

Indexed as

Gene Expression RegulationGene Knockdown TechniquesGenome-Wide Association StudyHepacivirusHepatitis C, ChronicHepatocytesHost-Pathogen InteractionsHumansLife Cycle StagesMicroRNAsMorphogenesisN-AcetylglucosaminyltransferasesUp-RegulationVirulenceMicroRNAsMIRN501 microRNA, humanMIRN-619 microRNA, humanN-AcetylglucosaminyltransferasesOGT protein, humanHCVhepatitis Chepatocytemolecular mechanisms

Identifiers

PMID31076402
PMCPMC7613422
OpenAlexW2944683054

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.